Ignite Creation Date:
2025-12-25 @ 1:25 AM
Ignite Modification Date:
2026-02-03 @ 5:50 AM
Study NCT ID:
NCT00295893
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-25
First Post:
2006-02-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer
Sponsor:
City of Hope Medical Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | inflammatory breast cancer | View |
| None | stage II breast cancer | View |
| None | stage IIIA breast cancer | View |
| None | stage IIIB breast cancer | View |
| None | stage IIIC breast cancer | View |
| None | male breast cancer | View |
| None | Paget disease of the breast with invasive ductal carcinoma | View |
| None | invasive ductal breast carcinoma with predominant intraductal component | View |
| None | invasive ductal breast carcinoma | View |
| None | medullary ductal breast carcinoma with lymphocytic infiltrate | View |
| None | comedo ductal breast carcinoma | View |
| None | invasive lobular breast carcinoma with predominant in situ component | View |
| None | invasive lobular breast carcinoma | View |
| None | mucinous ductal breast carcinoma | View |
| None | papillary ductal breast carcinoma | View |
| None | tubular ductal breast carcinoma | View |